Self-Injection Device – The New D-Flex
The D-Flex injection pen can do more than previous pens. D-Flex can be configured for...
Type 2 diabetes is a global health problem. According to expert estimates, the number of patients worldwide will increase by 48% by 2045.
Constantly elevated blood sugar levels mean stress for the blood vessels, which can lead to feared complications, including life-threatening sequelae such as a heart attack, organ failure or stroke.
A consistent treatment of Type 2 diabetes as early as possible can significantly improve the quality of life for the patient and the course of the disease.
The D-Flex injection pen can do more than previous pens. D-Flex can be configured for...
As an innovative, strategic partner company, Haselmeier develops and produces customised, unique systems that are...
Haselmeier and smart injector monitoring and support solutions company Common Sensing have announced a partnership...
Konrad Betzler was appointed the new chief quality officer (CQO) of the entire Haselmeier Group...